Sarepta Therapeutics, Inc. (SRPT): Price and Financial Metrics

SRPT POWR Grades

• Value is the dimension where SRPT ranks best; there it ranks ahead of 72.95% of US stocks.
• SRPT's strongest trending metric is Momentum; it's been moving down over the last 52 weeks.
• SRPT's current lowest rank is in the Momentum metric (where it is better than 9.55% of US stocks).

SRPT Stock Summary

• Of note is the ratio of Sarepta Therapeutics Inc's sales and general administrative expense to its total operating expenses; merely 12.93% of US stocks have a lower such ratio.
• With a price/sales ratio of 10.6, Sarepta Therapeutics Inc has a higher such ratio than 82.8% of stocks in our set.
• With a year-over-year growth in debt of 51.1%, Sarepta Therapeutics Inc's debt growth rate surpasses 86.69% of about US stocks.
• If you're looking for stocks that are quantitatively similar to Sarepta Therapeutics Inc, a group of peers worth examining would be CTMX, IDYA, JNCE, MEIP, and ASMB.
• Visit SRPT's SEC page to see the company's official filings. To visit the company's web site, go to www.sarepta.com.

SRPT Valuation Summary

• In comparison to the median Healthcare stock, SRPT's price/sales ratio is 8.37% lower, now standing at 10.4.
• SRPT's price/earnings ratio has moved up 3.9 over the prior 243 months.
• SRPT's price/sales ratio has moved down 648 over the prior 243 months.

Below are key valuation metrics over time for SRPT.

SRPT Growth Metrics

• The 5 year net income to common stockholders growth rate now stands at -198.11%.
• Its 4 year net cashflow from operations growth rate is now at 290.38%.
• Its 3 year revenue growth rate is now at 25713.33%.

SRPT's revenue has moved up $598,829,000 over the prior 67 months.

The table below shows SRPT's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-06-30	600.082	-702.238	-634.471
2021-03-31	573.356	-700.695	-703.886
2020-12-31	540.099	107.466	-554.128
2020-09-30	495.074	118.206	-600.514
2020-06-30	450.191	288.961	-530.341
2020-03-31	407.496	317.56	-655.924

SRPT's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• SRPT has a Quality Grade of C, ranking ahead of 59.3% of graded US stocks.
• SRPT's asset turnover comes in at 0.213 -- ranking 193rd of 680 Pharmaceutical Products stocks.
• LIFE, GLYC, and CBIO are the stocks whose asset turnover ratios are most correlated with SRPT.

The table below shows SRPT's key quality metrics over time.